Valuation: Bioneer Corporation

Market Cap 161B 105M 91.78M 84.6M 79.21M 149M 9.87B 152M 1.02B 393M 4.88B 393M 384M 16.92B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 174B 114M 99.73M 91.93M 86.06M 161M 10.73B 165M 1.1B 428M 5.3B 427M 418M 18.39B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
81.85%
Yield 2024 *
-
Yield 2025 -
1 day-5.90%
1 week-13.13%
Current month-30.27%
1 month-37.24%
3 months-48.17%
6 months-51.63%
Current year-51.22%
1 week 6,170
Extreme 6170
7,420
1 month 6,170
Extreme 6170
9,280
Current year 6,170
Extreme 6170
14,210
1 year 6,170
Extreme 6170
17,200
3 years 6,170
Extreme 6170
50,600
5 years 6,170
Extreme 6170
98,800
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 1992-07-31
Corporate Officer/Principal 62 2024-03-27
Corporate Officer/Principal 51 2025-03-30
Director TitleAgeSince
Director/Board Member 64 2011-02-17
Director/Board Member 61 1997-04-30
Director/Board Member 63 2000-01-31
Date Insider Type Main position Quantity % Market Cap.
25-06-11Fiscal year

Director

2,625 0.0102%
25-03-02Buy

Chief Executive Officer

3,000 0.0116%
25-01-21Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-5.90%-13.13%-57.69%-87.33% 105M
+0.33%+1.37%+63.66%+126.38% 55.63B
+0.82%+15.05%+79.52%+85.53% 52.25B
+1.36%+0.36%-14.52%-13.83% 23.07B
-1.04%+7.91%+3.91%+417.68% 22.41B
-0.18%+7.20%+31.37%-13.62% 17.32B
-1.10%+4.00%+29.97%-33.36% 15.94B
+2.89%+5.51%+25.42%+186.30% 13.77B
-3.35%+8.96%+134.32%+289.59% 13.47B
+1.31%+0.53%+27.83% - 12.43B
Average -0.49%+3.07%+32.38%+106.37% 22.64B
Weighted average by Cap. +0.26%+5.12%+48.45%+122.58%

Financials

2024 2025
Net sales 294B 192M 168M 155M 145M 272M 18.08B 278M 1.86B 721M 8.94B 720M 704M 30.99B 330B 215M 189M 174M 163M 305M 20.3B 312M 2.09B 809M 10.04B 808M 791M 34.8B
Net income -20.58B -13.42M -11.77M -10.85M -10.16M -19.04M -1.27B -19.44M -130M -50.45M -626M -50.4M -49.3M -2.17B -2.81B -1.83M -1.61M -1.48M -1.39M -2.6M -173M -2.66M -17.82M -6.89M -85.52M -6.89M -6.74M -297M
Net Debt -20.54B -13.39M -11.74M -10.82M -10.13M -19M -1.26B -19.4M -130M -50.34M -624M -50.29M -49.19M -2.16B 13.9B 9.06M 7.95M 7.32M 6.86M 12.86M 855M 13.12M 88.03M 34.06M 422M 34.03M 33.29M 1.47B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
26-06-26 ₩6,220.00 -5.90% 166,181
26-06-25 ₩6,610.00 -2.22% 141,654
26-06-24 ₩6,760.00 -0.44% 124,452
26-06-23 ₩6,790.00 -4.23% 138,512
26-06-22 ₩7,090.00 -0.98% 124,588
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock